Skip to main content
Premium Trial:

Request an Annual Quote

Products & Services: Jul 23, 2009


Thermo Fisher Scientific, the parent firm of Dharmacon, has announced the RNAi Discovery Grant Program.

The program will award more than $400,000 worth of the company's RNAi-based reagents through five awards made to researchers who submit research proposals for projects that "have the potential to significantly impact science and medicine."

Details on the awards, as well as information on submitting proposals, can be found here.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.